Latest Medical statistics Stories
JDP Therapeutics Inc., a privately held specialty pharmaceutical company, is pleased to announce that the Company’s Investigational New Drug (IND) to conduct an initial Phase 3 clinical trial
Achieved Negative Predictive Value and Sensitivity ~97% and Specificity ~38% CASTLE ROCK, Colo., March 13, 2014 /PRNewswire/ -- Venaxis, Inc. (Nasdaq: APPY), an
Salus IRB maintains a legacy of 28 years of continuous service coupled with expanded capabilities. Austin, Texas (PRWEB) March 12, 2014 RCRC IRB announced
Conference call to be held on Tuesday, March 11, 2014 at 4:30 p.m. Eastern Time BOTHELL, Wash.
SAN DIEGO, March 11, 2014 /PRNewswire/ -- Mast Therapeutics, Inc.
Connance Enhancements Meet the Growing Financial Challenges of Providers and Managing Patient Relationships Waltham, MA (PRWEB) March 06, 2014 Connance,
CLEVELAND, March 4, 2014 /PRNewswire/ -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced that it has entered into clinical trial
Experienced leaders form Provision Research Compliance Services, a joint venture between Schulman Associates IRB, Inc.
ROTTERDAM, Netherlands and BOSTON, Feb. 26, 2014 /PRNewswire/ -- Speed, efficiency and accuracy are vital to the success of clinical trials.
Analysis by the Company of Phase 3 efficacy studies of Nasal Mist Technology for Dental Anesthesia expected to be complete in the next thirty days. FORT COLLINS, Colo., Feb.
- One of a pair of round metal cymbals attached to the fingers and struck together for rhythm and percussion in belly dancing.